Cointime

Download App
iOS & Android

VIVUS

company
Funding Round
Post-IPO Equity
Money Raised
$ 33.60M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Caxton Advantage Life Sciences Fund - Yes - Detail